Ironwood beats estimates for Q2; new drug sales hit $29M

Stock in Ironwood Pharmaceuticals Inc. (Nasdaq: IRWD) rose as high as 9 percent Tuesday after the drug company reported revenues for the three months ending in June that blew away analyst estimates...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.